Hemolytic uremic syndrome in pediatric intensive care units in São Paulo, Brazil

Open Microbiology Journal

Volumn 5, Issue SUPPL.1, 2011, Pages 76-82

  de Souza, Renato Lopes ^a   Carvalhaes, João Tomás Abreu ^a   Nishimura, Lucilia Sanae ^a   de Andrade, Maria Cristina ^a   Guth, Beatriz Ernestina Cabilio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Children; Dialysis; Diarrhea; E. coli O157; Hemolytic Uremic Syndrome; Pediatric intensive care unit; Shiga toxin

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BRAZIL; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O111; ESCHERICHIA COLI O157; ESCHERICHIA COLI O165; ESCHERICHIA COLI O26; FEMALE; GENE SEQUENCE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; INFANT; INTENSIVE CARE UNIT; MALE; NEUROLOGIC DISEASE; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ESCHERICHIA COLI;

EID: 79961091762     PISSN: None     EISSN: 18742858     Source Type: Journal    
DOI: 10.2174/1874285801105010076     Document Type: Article

References (41)

1. Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989; 2: 15-38.
2. Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998; 11: 450-470.
3. Karmali, MA, Petric M, Lim C, Fleming PC, Steele BT. Escherichia coli cytotoxin, hemolytic-uremic syndrome, and haemorrhagic colitis. Lancet 1983; 2: 1299-1300.
4. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev 2004; 2: 123-140.
5. Caprioli A, Morabito S, Brugere H, Oswald E. Enterohemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res 2005; 36: 289-311.
6. Verweyen HM, Karch H, Brandis M, Zimmerhackl LB. Entero-hemorrhagic Escherichia coli infections: following transmission routes. Pediatr Nephrol 2000; 14: 73-83.
7. Repetto, HA. Epidemic hemolytic-uremic syndrome in children. Nephrology Forum. Kidney Int 1997; 52: 1708-1719.
8. Rivas M, Milwebsky E, Chinen I, Deza N, Leotta G. The epidemiology of hemolytic uremic syndrome in Argentina: diagnosis of the etiologic agent, reservoirs and routes of transmission. Medicina (B. Aires) 2006; 66: 27-32.
9. Pollard DR, Johnson WM, Lior H, Tyler SD, Rozee KR. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol 1990; 28: 540-545.
10. th Ed Elsevier Science Publishers: New York 1986.
11. Karch H, Schubert S, Zhang D, et al. A genomic island, termed high -pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun 1999; 67: 5994-6001.
12. Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 1995; 63: 1055-1061.
13. Gentry MK, Dalrymple JM. Quantitative microtiter cytotoxicity assay for Shigella toxin. J Clin Microbiol 1980; 12: 361-366.
14. Caprioli A, Luzzi I, Rosmini F, et al. Hus Italian Study Group. Hemolytic-Uremic Syndrome and Vero cytotoxin-producing E-scherichia coli infection in Italy. J Infect Dis 1992; 166: 154-158.
15. Tsutsumi R, Ichinohe N, Shimooki O, et al. Homologous and hete-rologous antibody responses to lipopolysaccharide after enterohe-morrhagic Escherichia coli infection. Microbiol Immunol 2004; 48: 27-38.
16. Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 1991; 337: 138-140.
17. Penna HAO, Manissadjian A, Okay Y. Síndrome Hemolítico-Urêmica (Microangiopatia Trombótica) - Apresentação de um Caso. Rev Hosp Clin Fac Med S Paulo 1967; 22: 295-302.
18. Carvalhaes JTA, Nóbrega FJ. Síndrome hemolítica urêmica (SHU) em gêmeos lactentes. Rev Paulista Pediatr 1983; 1: 18-22.
19. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002; 186: 493-500.
20. Decludt B, Bouvet P, Mariani-Kurkdjian P, et al. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. Epidemiol Infect 2000; 124: 215-220.
21. Lynn RM, O'Brien SJ, Taylor CM, et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 2005; 11: 590-596.
22. Tozzi AE, Caprioli A, Minelli F, et al. Hemolytic uremic syndrome study group. Emerg Infect Dis 2003; 9: 106-108.
23. Cantarelli V, Nagayama K, Takahashi A, et al. Isolation of Shiga toxin-producing Escherichia coli (STEC) serotype O91:H21 from a child with diarrhea in Porto Alegre city, RS, Brazil. Braz J Micro-biol 2000; 31: 266-270.
24. Guth BEC, Ramos SRTS, Cerqueira AMF, Andrade JRC, Gomes TAT. Phenotypic and genotypic characteristics of Shiga toxin-producing Escherichia coli strains isolated from children in São Paulo, Brazil. Mem Inst Oswaldo Cruz 2002; 97: 1085-1089.
25. Irino K, Vaz TMI, Kato MAMF, et al. O157:H7 Shiga toxin-producing Escherichia coli strains associated with sporadic cases of diarrhea in São Paulo, Brazil. Emerg Infect Dis 2002; 8: 446-447.
26. Vaz TMI, Irino K, Kato MAMF, et al. Virulence properties and characteristics of Shiga toxin-producing Escherichia coli in São Paulo, Brazil, from 1976 trough 1999. J Clin Microbiol 2004; 42: 903-905.
27. Guth BEC, Vaz TMI, Gomes TAT, et al. Re-emergence of O103:H2 Shiga toxin-producing Escherichia coli infections in São Paulo, Brazil. J Med Microbiol 2005; 54: 805-806.
28. Orlandi PP, Magalhães GF, Matos NB, et al. Etiology of diarrheal infections in children of Porto Velho (Rondonia, Western Amazon region, Brazil). Braz J Med Biol Res 2006; 39: 507-517.
29. Franzolin MR, Alves RCB, Keller R, et al. Prevalence of diarrhea-genic Escherichia coli in children with diarrhea in Salvador, Bahia, Brazil. Mem Inst Oswaldo Cruz 2005; 100: 359-363.
30. Irino K, Vaz TMI, Medeiros MIC, et al. Serotype diversity as a drawback in the surveillance of Shiga toxin-producing Escherichia coli infections in Brazil. J Med Microbiol 2007; 56: 565-567.
31. De Toni F, Souza EM, Pedrosa FO, et al. A prospective study on Shiga toxin-producing Escherichia coli in children with diarrhoea in Paraná State, Brazil. Lett Appl Microbiol 2009; 48: 645-647.
32. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Es-cherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073-1086.
33. Banatvala N, Griffin PM, Greene KD, et al. The United State national prospective hemolytic uremic syndrome study: microbiolo-gic, srologic, clinical, and epidemiologic findings. J Infect Dis 2001; 183: 1063-1070.
34. Guth BEC, Souza RL, Vaz TMI, Irino K. First Shiga toxin-producing Escherichia coli isolated from a patient with hemolytic uremic syndrome, Brazil. Emerg Infect Dis 2002; 8: 535.
35. Souza RL, Nishimura LS, Guth BEC. Uncommon Shiga toxin-producing Escherichia coli serotype O165:HNM as cause of hemo-lytic uremic syndrome in São Paulo, Brazil - Case Report. Diagn Microbiol Infect Dis 2007; 59: 223-225.
36. Thomas A, Cheasty T, Frost JA, Chart H, Smith HR, Rowe B. Verocytoxin producing E. coli, particulary serogroup O157, associated with human infections in England and Wales: 1992-94. Epidemiol Infect 1996; 117: 1-10.
37. Gomes TAT, Griffin PM, Ivey C, Trabulsi LR, Ramos SRTS. EPEC Infections in São Paulo. Rev Microbiol 1996; 27: 25-33.
38. Espié E, Vaillant V, Mariani-Kurkdjian P, et al. Escherichia coli O157 outbreak associated with fresh unpasteurized goatś cheese. Epidemol Infect 2006; 134: 143-146.
39. Perez N, Rahman R, Zalva J, Bibiloni N, Lasarte P, Spizirri F. HUS and unpasteurized milk. Acta Pediatr 1994; 83: 142.
40. Miliwebsky ES, Balbi L, Gomez D, et al. Síndrome urémico hemolítico em niños de Argentina: asociación com la infección por Escherichia coli productor de toxina shiga. Bioquimica y Patologia Clinica 1999; 63: 113-121.
41. Cavagnaro FSM, Gana JCA, Lagomarsino EF, Vogel AS, Gederlini AG. Síndrome hemolítico urémico. Experiência de um centro pediátrico. Rev Méd Chile 2005; 133: 781-787.